Literature DB >> 6864397

Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families.

M A Tucker, M H Greene, W H Clark, K H Kraemer, M C Fraser, D E Elder.   

Abstract

Four prepubertal children, all members of melanoma-prone families, developed pigmented scalp lesions that were diagnosed as dysplastic nevi. In three cases, the scalp lesions were the only evidence that the children were affected by the dysplastic nevus syndrome, a distinctive clinicopathologic entity that identifies persons at increased risk of malignant melanoma. In general, the skin of family members with dysplastic nevus syndrome does not show characteristic lesions until just prior to or with the onset of puberty. The presence of dysplastic nevi on the scalp may permit identification of at least some high-risk family members well prior to puberty. This should facilitate the early implementation of a melanoma prevention program for susceptible individuals and help ensure that melanomas are diagnosed early in their natural history, at a time when they are surgically curable.

Entities:  

Mesh:

Year:  1983        PMID: 6864397     DOI: 10.1016/s0022-3476(83)80777-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.

Authors:  A M Goldstein; L R Goldin; N C Dracopoli; W H Clark; M A Tucker
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

Review 2.  Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma.

Authors:  Emily S Tonorezos; Danielle Novetsky Friedman; Dana Barnea; Machteld I Bosscha; Guillermo Chantada; Charlotte J Dommering; Pim de Graaf; Ira J Dunkel; Armida W M Fabius; Jasmine H Francis; Mary-Louise C Greer; Ruth A Kleinerman; Wijnanda A Kors; Suzanne Laughlin; Annette C Moll; Lindsay M Morton; Petra Temming; Margaret A Tucker; Flora E van Leeuwen; Michael F Walsh; Kevin C Oeffinger; David H Abramson
Journal:  Ophthalmology       Date:  2020-05-15       Impact factor: 12.079

3.  The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

4.  Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity.

Authors:  A M Goldstein; N C Dracopoli; E C Ho; M C Fraser; K S Kearns; S J Bale; O W McBride; W H Clark; M A Tucker
Journal:  Am J Hum Genet       Date:  1993-03       Impact factor: 11.025

5.  Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.

Authors:  Xiaohong Rose Yang; Ruth M Pfeiffer; William Wheeler; Meredith Yeager; Stephen Chanock; Margaret A Tucker; Alisa M Goldstein
Journal:  Int J Cancer       Date:  2009-12-15       Impact factor: 7.396

Review 6.  Melanoma risk factors and atypical moles.

Authors:  M L Williams; R W Sagebiel
Journal:  West J Med       Date:  1994-04

7.  Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy.

Authors:  S J Bale; A Chakravarti; M H Greene
Journal:  Am J Hum Genet       Date:  1986-02       Impact factor: 11.025

8.  Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.

Authors:  A M Goldstein; N C Dracopoli; M Engelstein; M C Fraser; W H Clark; M A Tucker
Journal:  Am J Hum Genet       Date:  1994-03       Impact factor: 11.025

9.  Pediatric melanoma in melanoma-prone families.

Authors:  Alisa M Goldstein; Kelsey C Stidd; Xiaohong R Yang; Mary C Fraser; Margaret A Tucker
Journal:  Cancer       Date:  2018-09-12       Impact factor: 6.860

10.  Increased Risk of Skin Cancer in 1,851 Long-Term Retinoblastoma Survivors.

Authors:  Ruth A Kleinerman; Sara J Schonfeld; David H Abramson; Jasmine H Francis; Johanna M Seddon; Lindsay M Morton; Margaret A Tucker
Journal:  J Invest Dermatol       Date:  2021-06-18       Impact factor: 7.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.